We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Balanced Reporting. Trusted Insights.
Thursday, September 28, 2023
The Food and Drug Administration is calling for a new “regulatory pathway” to allow for the use of use of cannabidiol, or CBD, in dietary supplements and food additives, after concluding that “it is not apparent how CBD products could meet safety standards” for those products.
Four years after the farm bill legalized industrial hemp nationwide, crop acreage is falling as the industry struggles to get regulatory clarity and infrastructure for products derived from the plant’s grain and fiber.
Hemp supporters are touting the crop's myriad uses and soil-nurturing properties while pushing some ideas for increasing its viability as Congress prepares to update the 2018 farm bill that sparked a growing interest.
A federal judge has reversed the Trump administration's decision to delist the gray wolf under the Endangered Species Act, restoring protections for an animal often at odds with ranchers and livestock.
The rush to plant hemp for CBD production as well as the legalization of marijuana in many states has created a conflict for those wanting to grow hemp for grain or fiber.
Hemp industry stakeholders are pushing for regulatory certainty as one of the crop's chief byproducts gains in popularity and interest from a curious consumer base.
The industrial hemp industry’s “green rush,” which began in mid-2017, has cooled, at least for those growing hemp for the cannabidiol (CBD) market and many companies that process it.
Many in the hemp industry are worried a new Drug Enforcement Administration rule will make processors vulnerable to enforcement under the Controlled Substances Act, and some are looking at filing a lawsuit to challenge it.
